Cantor Fitzgerald Estimates CVS Health FY2025 Earnings

CVS Health Co. (NYSE:CVS) – Stock analysts at Cantor Fitzgerald issued their FY2025 EPS estimates for shares of CVS Health in a research report issued to clients and investors on Tuesday, January 21st. Cantor Fitzgerald analyst S. James expects that the pharmacy operator will post earnings per share of $5.71 for the year. Cantor Fitzgerald has a “Neutral” rating and a $62.00 price objective on the stock. The consensus estimate for CVS Health’s current full-year earnings is $5.22 per share.

CVS Health (NYSE:CVS) last issued its quarterly earnings data on Wednesday, November 6th. The pharmacy operator reported $1.09 EPS for the quarter, topping the consensus estimate of $1.08 by $0.01. CVS Health had a return on equity of 10.72% and a net margin of 1.36%. The company had revenue of $95.43 billion during the quarter, compared to analyst estimates of $92.72 billion. During the same quarter in the previous year, the firm earned $2.21 earnings per share. CVS Health’s revenue was up 6.3% on a year-over-year basis.

A number of other research analysts have also recently commented on the company. UBS Group increased their target price on CVS Health from $60.00 to $62.00 and gave the company a “neutral” rating in a research note on Thursday, November 7th. Deutsche Bank Aktiengesellschaft upgraded CVS Health from a “hold” rating to a “buy” rating and set a $66.00 target price for the company in a research report on Tuesday, December 3rd. Wells Fargo & Company upgraded shares of CVS Health from an “equal weight” rating to an “overweight” rating and increased their price target for the company from $60.00 to $66.00 in a research report on Monday, November 18th. Piper Sandler lowered their price objective on shares of CVS Health from $72.00 to $64.00 and set an “overweight” rating for the company in a report on Monday, November 25th. Finally, TD Cowen increased their target price on shares of CVS Health from $73.00 to $80.00 and gave the company a “buy” rating in a report on Monday, November 25th. One equities research analyst has rated the stock with a sell rating, six have given a hold rating and thirteen have issued a buy rating to the stock. According to MarketBeat, CVS Health has an average rating of “Moderate Buy” and a consensus price target of $68.71.

CVS Health Price Performance

Shares of NYSE:CVS opened at $53.05 on Thursday. CVS Health has a one year low of $43.56 and a one year high of $80.75. The company has a debt-to-equity ratio of 0.80, a current ratio of 0.80 and a quick ratio of 0.59. The firm has a market capitalization of $66.76 billion, a price-to-earnings ratio of 13.46, a PEG ratio of 0.80 and a beta of 0.59. The company’s fifty day moving average price is $51.23 and its 200-day moving average price is $56.24.

CVS Health Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Monday, February 3rd. Shareholders of record on Thursday, January 23rd will be given a $0.665 dividend. This represents a $2.66 dividend on an annualized basis and a yield of 5.01%. The ex-dividend date is Thursday, January 23rd. CVS Health’s payout ratio is 67.51%.

Institutional Inflows and Outflows

Hedge funds have recently made changes to their positions in the stock. MidAtlantic Capital Management Inc. purchased a new stake in shares of CVS Health in the third quarter worth $25,000. Ridgewood Investments LLC boosted its holdings in CVS Health by 255.7% in the 4th quarter. Ridgewood Investments LLC now owns 626 shares of the pharmacy operator’s stock worth $28,000 after buying an additional 450 shares during the period. Livelsberger Financial Advisory bought a new stake in CVS Health during the third quarter valued at about $31,000. Legacy Investment Solutions LLC purchased a new position in shares of CVS Health in the third quarter valued at about $31,000. Finally, Reston Wealth Management LLC bought a new position in shares of CVS Health in the third quarter worth about $32,000. 80.66% of the stock is currently owned by institutional investors.

About CVS Health

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.